Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia

• Main Authors: Ashwin Jacob Mathai (Author), Jyoti Kanwar (Author), Olaoluwa Okusaga (Author), Dietmar Fuchs (Author), Christopher A Lowry (Author), Xiaoqing Peng (Author), Ina Giegling (Author), Annette M Hartmann (Author), Bettina Konte (Author), Marion Friedl (Author), Claudia Gragnoli (Author), Gloria M Reeves (Author), Maureen Groer (Author), Richard N Rosenthal (Author), Dan Rujescu (Author), Teodor T Postolache (Author)
• Format: Book
• Published: Frontiers Media S.A., 2016-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Smoking is highly prevalent in patients with schizophrenia and exerts a negative impact on cardiovascular mortality in these patients. Smoking has complex interactions with monoamine metabolism through the ability of cigarette smoke to suppress Type 1 T helper cell (Th1) type immunity, the immunophe...